In a major push to strengthen India's affordable medicine network, the Pharmaceuticals & Medical Devices Bureau of India (PMBI) has announced a series of measures aimed at improving the financial viability of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) stores. The changes include a significant increase in retailer margins, extended credit facilities and additional support for distributors.
As US President Donald Trump announces new tariffs, India's pharmaceutical industry is safe—for now—showing how important it is to American healthcare.
New Delhi, India -...
